Search clinical trials for: Inspra 50 mg Tablets GD Searle LLC, USA

Total 11 results

Sandoz

Completed

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions

Hypertension
Sandoz

Completed

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions

Hypertension
Sandoz

Completed

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Prostate Cancer | Hirsutism
Sandoz

Completed

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Prostate Cancer | Hirsutism
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

Pain
Darnitsa Pharmaceutical Company
ACDIMA Biocenter

Completed

Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
University of Cincinnati

Withdrawn

Eplerenone as a Supplement to Epidural Steroid Injections

Low Back Pain | Sciatic Radiculopathy | Degenerative Intervertebral Discs

United States
National Institute of Pediatrics, Mexico
Hospital Infantil de Mexico Federico Gomez

Terminated

Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.

Oral Mucositis

Mexico
Université de Sherbrooke

Completed

Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10) (GB10)

Obesity | Type 2 Diabetes

Canada
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditions

United States, Puerto Rico
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Metastatic Malignant Neoplasm in the Liver | Advanced Malignant Neoplasm | Refractory Malignant Neoplasm | Colorectal Carcinoma Metastatic in the Liver

United States

Search clinical trials for: Inspra 50 mg Tablets GD Searle LLC, USA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations